1. Combination treatment of gemcitabine and sorafenib exerts a synergistic inhibitory effect on non‑small cell lung cancer in�vitro and in�vivo via the epithelial‑to‑mesenchymal transition process
    Shanshan Jiang et al, 2020, Oncology Letters CrossRef
  2. Piceatannol Enhances the Antitumor Efficacy of Gemcitabine in Human A549 Non-Small Cell Lung Cancer Cells
    Bin Xu et al, 2015, Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics CrossRef
  3. Antiangiogenic agents combined with chemotherapy in non-small cell lung cancer
    Shanshan Chen et al, 2015, Oncology and Translational Medicine CrossRef
  4. Efficient synthesis and biological activity of Psammaplin A and its analogues as antitumor agents
    Suckchang Hong et al, 2015, European Journal of Medicinal Chemistry CrossRef
  5. The cell line models to study tyrosine kinase inhibitors in non-small cell lung cancer with mutations in the epidermal growth factor receptor: A scoping review
    Alessia Belloni et al, 2024, Critical Reviews in Oncology/Hematology CrossRef
  6. Pharmacological bioactivity of Ceratonia siliqua pulp extract: in vitro screening and molecular docking analysis, implication of Keap-1/Nrf2/NF-ĸB pathway
    Marwa El-Zeftawy et al, 2023, Scientific Reports CrossRef
  7. Synergistic interaction between MEK inhibitor and gefitinib in EGFR-TKI-resistant human lung cancer cells
    SUXIA LI et al, 2015, Oncology Letters CrossRef
  8. Trichosanthin enhances the antitumor effect of gemcitabine in non‑small cell lung cancer via inhibition of the PI3K/AKT pathway
    Naren Tuya et al, 2017, Experimental and Therapeutic Medicine CrossRef
  9. Efficacy and Safety of Sorafenib for Advanced Non-Small Cell Lung Cancer: a Meta-analysis of Randomized Controlled Trials
    Wei-Lan Wang et al, 2014, Asian Pacific Journal of Cancer Prevention CrossRef
  10. Pharmacokinetic/pharmacodynamic modeling of combination-chemotherapy for lung cancer
    Louis T. Curtis et al, 2018, Journal of Theoretical Biology CrossRef
  11. Adverse Toxic Effects of Tyrosine Kinase Inhibitors on Non-Target Zebrafish Liver (ZFL) Cells
    Katja Kološa et al, 2023, International Journal of Molecular Sciences CrossRef
  12. Alantolactone enhances gemcitabine sensitivity of lung cancer cells through the reactive oxygen species-mediated endoplasmic reticulum stress and Akt/GSK3β pathway
    Jiquan Wang et al, 2019, International Journal of Molecular Medicine CrossRef
  13. Cucurbitacin E Exerts Anti-Proliferative Activity via Promoting p62-Dependent Apoptosis in Human Non-Small-Cell Lung Cancer A549 Cells
    Han-Lin Hsu et al, 2023, Current Issues in Molecular Biology CrossRef